• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Neoadjuvant immunotherapy is safe before surgery in head and neck squamous cell carcinoma. Is it time to challenge the standard-of-care?

作者信息

Gross Neil D, Seiwert Tanguy Y

机构信息

Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA.

出版信息

Cancer. 2024 Mar 15;130(6):846-847. doi: 10.1002/cncr.35198. Epub 2024 Jan 18.

DOI:10.1002/cncr.35198
PMID:38236709
Abstract
摘要

相似文献

1
Neoadjuvant immunotherapy is safe before surgery in head and neck squamous cell carcinoma. Is it time to challenge the standard-of-care?新辅助免疫疗法在头颈部鳞状细胞癌手术前是安全的。是时候挑战标准治疗方案了吗？
Cancer. 2024 Mar 15;130(6):846-847. doi: 10.1002/cncr.35198. Epub 2024 Jan 18.
2
The Ethics of Palliative Surgery for Locally Advanced Head and Neck Squamous Cell Carcinoma.局部晚期头颈部鳞状细胞癌姑息性手术的伦理学
Otolaryngol Head Neck Surg. 2023 Sep;169(3):738-740. doi: 10.1002/ohn.378. Epub 2023 May 20.
3
[Advances in neoadjuvant immunotherapy for locally advanced head and neck squamous cell carcinoma].[局部晚期头颈部鳞状细胞癌新辅助免疫治疗的进展]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022 Oct 7;57(10):1271-1276. doi: 10.3760/cma.j.cn115330-20220620-00360.
4
Neoadjuvant Immunotherapy for Head and Neck Squamous Cell Carcinoma: Expecting Its Application in Temporal Bone Squamous Cell Carcinoma.头颈部鳞状细胞癌的新辅助免疫疗法：期待其在颞骨鳞状细胞癌中的应用。
Curr Med Sci. 2023 Apr;43(2):213-222. doi: 10.1007/s11596-023-2700-2. Epub 2023 Mar 26.
5
Rationale for neoadjuvant immunotherapy in head and neck squamous cell carcinoma.头颈部鳞状细胞癌新辅助免疫治疗的理由。
Oral Oncol. 2017 Oct;73:65-69. doi: 10.1016/j.oraloncology.2017.08.008. Epub 2017 Aug 17.
6
[Overview and prospects of neoadjuvant immunotherapy in head and neck squamous cell carcinoma].头颈部鳞状细胞癌新辅助免疫治疗的概述与展望
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024 Apr 7;59(4):301-305. doi: 10.3760/cma.j.cn115330-20240129-00052.
7
Case report: Patient specific combination of surgery and immunotherapy in advanced squamous cell carcinoma of the head and neck - a case series and review of literature.病例报告：手术和免疫治疗联合应用于晚期头颈部鳞状细胞癌的个体化治疗 - 病例系列及文献复习。
Front Immunol. 2022 Oct 27;13:970823. doi: 10.3389/fimmu.2022.970823. eCollection 2022.
8
Outcomes of Treatment With Neoadjuvant Cemiplimab for Patients With Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck: Secondary Analysis of a Phase 2 Clinical Trial.新辅助西米普利单抗治疗晚期可切除头颈部皮肤鳞状细胞癌患者的疗效：一项2期临床试验的二次分析
JAMA Otolaryngol Head Neck Surg. 2023 Sep 1;149(9):847-849. doi: 10.1001/jamaoto.2023.1729.
9
[Research progress on neoadjuvant immunotherapy for locally advanced head and neck squamous cell carcinoma].[局部晚期头颈部鳞状细胞癌新辅助免疫治疗的研究进展]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024 Feb 7;59(2):187-191. doi: 10.3760/cma.j.cn115330-20231031-00178.
10
Genomics and precision surgery for head and neck squamous cell carcinoma.头颈部鳞状细胞癌的基因组学与精准外科
Cancer Lett. 2020 Jul 1;481:45-54. doi: 10.1016/j.canlet.2020.04.004. Epub 2020 Apr 6.

引用本文的文献

1
T cell dynamics with neoadjuvant immunotherapy in head and neck cancer.头颈部癌新辅助免疫治疗中的T细胞动力学
Nat Rev Clin Oncol. 2025 Feb;22(2):83-94. doi: 10.1038/s41571-024-00969-w. Epub 2024 Dec 10.